Gps Wealth Strategies Group, LLC Arrowhead Pharmaceuticals, Inc. Transaction History
Gps Wealth Strategies Group, LLC
- $726 Million
- Q3 2024
A detailed history of Gps Wealth Strategies Group, LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Gps Wealth Strategies Group, LLC holds 18 shares of ARWR stock, worth $342. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18
Previous 18
-0.0%
Holding current value
$342
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ARWR
# of Institutions
296Shares Held
91.1MCall Options Held
155KPut Options Held
426K-
Black Rock Inc. New York, NY15.7MShares$298 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$233 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.89MShares$169 Million2.59% of portfolio
-
State Street Corp Boston, MA6.35MShares$121 Million0.01% of portfolio
-
Slate Path Capital LP New York, NY4.89MShares$92.9 Million1.49% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $2.01B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...